2013
DOI: 10.1055/s-0033-1358367
|View full text |Cite
|
Sign up to set email alerts
|

Early Identification and Treatment of Communication and Swallowing Deficits in Parkinson Disease

Abstract: Parkinson disease (PD) is a complex, progressive, neurodegenerative disorder that leads to a wide range of deficits including fine and gross sensorimotor impairment, autonomic dysfunction, mood disorders, and cognitive decline. Traditionally, the focus for diagnosis and treatment has been on sensorimotor impairment related to dopamine depletion. It is now widely recognized, however, that PD-related pathology affects multiple central nervous system neurotransmitters and pathways. Communication and swallowing fu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
24
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(26 citation statements)
references
References 100 publications
2
24
0
Order By: Relevance
“…In the case of PD, patients have reduced vocal quality (e.g., breathiness or roughness), intensity (loudness), inflection, and articulation [19, 39, 40], even in the early stages of disease progression [1]. Changes in vocalizations in animal models of PD have been demonstrated in several model species.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In the case of PD, patients have reduced vocal quality (e.g., breathiness or roughness), intensity (loudness), inflection, and articulation [19, 39, 40], even in the early stages of disease progression [1]. Changes in vocalizations in animal models of PD have been demonstrated in several model species.…”
Section: Discussionmentioning
confidence: 99%
“…These changes can occur early in disease progression, especially in Parkinson’s disease (PD) and Alzheimer’s disease (AD) [1, 2], in some cases even before diagnosis [3, 4]. Animal models of these diseases are important for translational medicine, including development and testing of new drug and behavioral treatments [5, 6, 7, 8].…”
Section: Introductionmentioning
confidence: 99%
“…However, treatment is often not initiated until the patient is seen by a speech-language pathologist; this may not occur until late in the progression of the disease, as many patients do not report symptoms despite having dysphagia [2]. Early identification of swallowing deficits in individuals with PD may allow for earlier, preventative intervention and thus improved health and quality of life outcomes [12]. Nonetheless, swallowing changes in the early stages of PD are not well described.…”
Section: Introductionmentioning
confidence: 99%
“…As the disease progresses, up to 90% of individuals have significant voice deficits that negatively impact quality of life and are difficult to treat [14]. Importantly, there is evidence that these changes in voice manifest prior to the onset of cardinal signs of the disease (resting tremor, bradykinesia and muscle rigidity) that are typically associated with significant striatal dopamine loss [5].…”
Section: Introductionmentioning
confidence: 99%